{"eventGroups":[{"description":"reduced intensisty transplant are those that do not completely eliminate the patient's stem cells prior to recieving the bone marrow transplant","id":"EG000","otherNumAffected":0,"otherNumAtRisk":65,"seriousNumAffected":6,"seriousNumAtRisk":65,"title":"Reduced Intensity Allogeneic Cell Transplantation"}],"frequencyThreshold":"5","seriousEvents":[{"assessmentType":"NON_SYSTEMATIC_ASSESSMENT","organSystem":"Immune system disorders","sourceVocabulary":"CTCAE (3.0)","stats":[{"groupId":"EG000","numAffected":3,"numAtRisk":65,"numEvents":3}],"term":"Graft versus host disease"},{"assessmentType":"NON_SYSTEMATIC_ASSESSMENT","organSystem":"Immune system disorders","sourceVocabulary":"CTCAE (3.0)","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":65,"numEvents":1}],"term":"Post transplant proliferative disorder"},{"assessmentType":"NON_SYSTEMATIC_ASSESSMENT","organSystem":"Nervous system disorders","sourceVocabulary":"CTCAE (3.0)","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":65,"numEvents":1}],"term":"Neurological unspecified"},{"assessmentType":"NON_SYSTEMATIC_ASSESSMENT","notes":"Cause of death could not be determined. Per study, this was considered related to transplant","organSystem":"General disorders","sourceVocabulary":"CTCAE (3.0)","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":65,"numEvents":1}],"term":"Death of unknown cause"}],"timeFrame":"The only adverse events collected and analyzed for this study were grade 5 (death) related to transplant occurring within 6 months of transplant. No data was collected for less serious adverse events."}